Should he win reelection, President Donald Trump’s second-term healthcare agenda would largely be a continuation of the first. The president has proposed coverage for preexisting conditions. He has vowed to continue to press for lower drug prices and insurance premiums, end “surprise billing” and create tax incentives for essential industries such as pharmaceutical companies that increase domestic manufacturing.
HRI boiled down Trump’s second-term priorities into one graphic, along with the proposals’ likelihood of gaining traction and implications for industry. Should he win, HRI will publish a comprehensive report on his healthcare agenda for a second term.